Basic information Safety Supplier Related

4-broMo-7-fluoro-2,3-dihydroinden-1-one

Basic information Safety Supplier Related

4-broMo-7-fluoro-2,3-dihydroinden-1-one Basic information

Product Name:
4-broMo-7-fluoro-2,3-dihydroinden-1-one
Synonyms:
  • 4-broMo-7-fluoro-2,3-dihydroinden-1-one
  • 4-BroMo-7-fluoro-2,3-dihydro-1H-inden-1-one
  • 4-Bromo-2,3-dihydro-7-fluoro-1H-inden-1-one, 4-Bromo-2,3-dihydro-7-fluoro-1-oxo-1H-indene
  • 4-Bromo-7-fluoroindan-1-one
  • 4-Bromo-7-fluoro-1-indanone
  • 4-Bromo-7-fluoro-2,3-dihydro-1-indanone
  • 4-Bromo-7-fL
  • uoro-2,3-dihydro-1H-inden-1-one
CAS:
1003048-72-3
MF:
C9H6BrFO
MW:
229.05
EINECS:
810-183-6
Mol File:
1003048-72-3.mol
More
Less

4-broMo-7-fluoro-2,3-dihydroinden-1-one Chemical Properties

Boiling point:
310.7±42.0 °C(Predicted)
Density 
1.691±0.06 g/cm3(Predicted)
storage temp. 
Sealed in dry,Room Temperature
form 
solid
color 
White to yellow
InChI
InChI=1S/C9H6BrFO/c10-6-2-3-7(11)9-5(6)1-4-8(9)12/h2-3H,1,4H2
InChIKey
HNXHWYGTXAJDEC-UHFFFAOYSA-N
SMILES
C1(=O)C2=C(C(Br)=CC=C2F)CC1
More
Less

Safety Information

HS Code 
2914390090
More
Less

4-broMo-7-fluoro-2,3-dihydroinden-1-one Usage And Synthesis

Uses

4-?Bromo-?7-?fluoro-?2,?3-?dihydroinden-?1-?one is a reactant or reagent used in the preparation of indanyloxydihydrobenzofuranylacetic acids which are suitable for treatment of metabolic diseases.

Synthesis

651735-59-0

1003048-72-3

General procedure for the synthesis of 4-bromo-7-fluoroindanone using 7-fluoro-2,3-dihydro-1H-inden-1-one as starting material: 7-fluoro-2,3-dihydro-1H-inden-1-one (5.3 g, 35.3 mmol) was added to a solution of aluminum chloride (11.77 g, 88 mmol) in dichloroethane (100 mL) at room temperature, followed by a slow, dropwise addition of bromine ( 1.91 mL, 37.1 mmol). The reaction mixture was heated at 65 °C with stirring for 16 hours. Upon completion of the reaction, the mixture was cooled to room temperature and carefully poured into a mixture of ice and 1N aqueous hydrochloric acid solution. The mixture was extracted with ether (200 mL x 2) and the organic phases were combined. The organic phase was dried with anhydrous magnesium sulfate, filtered and concentrated under reduced pressure. The crude product was purified by silica gel column chromatography with an eluent gradient of 0-10% ethyl acetate/hexane to give 4-bromo-7-fluoroindanone (5.2 g, 64% yield). The mass spectrum (DC1/NH3) showed m/z 246 (M + NH4)+.

References

[1] Patent: US2013/158067, 2013, A1. Location in patent: Paragraph 0540
[2] Patent: WO2018/172852, 2018, A1. Location in patent: Page/Page column 102; 103

4-broMo-7-fluoro-2,3-dihydroinden-1-oneSupplier

Tongchuang Pharma(Suzhou). Co., Ltd. Gold
Tel
0512-63263366 18912765016
Email
tongtf110@sina.com
Bellen Chemistry Co., Ltd. Gold
Tel
010-60400365-8001 15910885229
Email
service@bellenchem.com
Suzhou Xinghuo Biotechnology Co., Ltd. Gold
Tel
19945655289
Email
xinghuoshengwu@163.com
Suzhou Liyuan Biomedical Technology Co., Ltd. Gold
Tel
0557-18949975665 18949975665
Email
1184800090@qq.com
Energy Chemical
Tel
021-021-58432009 400-005-6266
Email
sales8178@energy-chemical.com